Product Information
VERAPAMIL SR 360 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $8.0492 per EA under NDC 00591288601. Its NADAC has been published 658 times since Nov 28, 2013.
Strength
360 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00591288601
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA019614On Market Since
5/29/1990
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL SR 360 MG CAPSULE has been published 658 times since Nov 28, 2013, and over the history we have for it it has risen 467.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0492 per EA |
|---|---|
| All-time high | $8.4534 (May 13, 2026) |
| All-time low | $1.3912 (Jan 21, 2015) |
| 52-week high | $8.4534 |
| 52-week low | $4.4026 |
| Median price | $4.2733 |
| Average price | $4.0425 |
| Largest weekly change | +84.6% (May 20, 2015) |
| Weeks tracked | 658 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL SR 360 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 360 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $8.0492 per EA (NDC 00591288601), effective Jul 1, 2026.
How has the price of VERAPAMIL SR 360 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL SR 360 MG CAPSULE has risen 467.2%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 360 MG CAPSULE?
Since Nov 28, 2013, the NADAC for VERAPAMIL SR 360 MG CAPSULE has ranged from a low of $1.3912 (Jan 21, 2015) to a high of $8.4534 (May 13, 2026), with a median of $4.2733 per EA.
Are there cheaper alternatives to VERAPAMIL SR 360 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VERAPAMIL SR 360 MG CAPSULE, but none are currently priced below it.
Who manufactures VERAPAMIL SR 360 MG CAPSULE?
VERAPAMIL SR 360 MG CAPSULE (NDC 00591288601) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification